This technology is a deep-contrast AI-enabled algorithm to predict blood-brain barrier (BBB) openings from T1 MRI sequences using low doses of gadolinium-based contrast agents (GBCA).
This technology is an optical computed tomography (CT) scanner that produces fast and accurate 3D dosimeter readings for radiotherapy dose verification.